Cargando…

What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women

INTRODUCTION: Women at high inherited risk of ovarian cancer are advised to undergo risk-reducing bilateral salpingo-oophorectomy (RRBSO) at age 40–45 years or when their families are complete. Most women are premenopausal at this age, so RRBSO will induce surgical menopause. Despite the clear benef...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickey, Martha, Trainer, Alison, Braat, Sabine, Davey, Mary-Ann, Krejany, Efrosinia, Wark, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695307/
https://www.ncbi.nlm.nih.gov/pubmed/29138210
http://dx.doi.org/10.1136/bmjopen-2017-018758
_version_ 1783280289563279360
author Hickey, Martha
Trainer, Alison
Braat, Sabine
Davey, Mary-Ann
Krejany, Efrosinia
Wark, John
author_facet Hickey, Martha
Trainer, Alison
Braat, Sabine
Davey, Mary-Ann
Krejany, Efrosinia
Wark, John
author_sort Hickey, Martha
collection PubMed
description INTRODUCTION: Women at high inherited risk of ovarian cancer are advised to undergo risk-reducing bilateral salpingo-oophorectomy (RRBSO) at age 40–45 years or when their families are complete. Most women are premenopausal at this age, so RRBSO will induce surgical menopause. Despite the clear benefits of RRBSO for cancer risk reduction, much less is known about the impact on non-cancer outcomes that contribute to health and well-being and inform surveillance and management strategies. METHODS AND ANALYSIS: This will be a multicentre, prospective cohort study of 105 premenopausal high-risk women undergoing RRBSO and an age-matched comparison group of 105 premenopausal women not planning oophorectomy or pregnancy in the next 2 years. The aim of this study is to measure the impact of RRBSO on sexual function (primary outcome) at 24 months in high-risk premenopausal women compared with the comparison group. Secondary outcomes include menopausal symptoms and menopause-related quality of life, mood, sleep quality, markers of cardiovascular disease and pre-diabetes, bone density and markers of bone turnover, and the impact of hormone replacement therapy use on these outcomes. Data analysis methods will include logistic and linear regression using general estimating equations accounting for the repeated outcome measurements within each participant. ETHICS AND DISSEMINATION: The study has been approved by institutional ethics committees at each participating centre. Findings will be disseminated through peer-reviewed publications and conference presentations, and national and international networks of centres managing high-risk women, and will inform national and international clinical guidelines. TRIAL REGISTRATION NUMBER: The pre-results protocol for this trial is registered with the Australian New Zealand Clinical Trials Registry (anzctr.org.au; registration no: ACTRN12615000082505).
format Online
Article
Text
id pubmed-5695307
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56953072017-11-24 What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women Hickey, Martha Trainer, Alison Braat, Sabine Davey, Mary-Ann Krejany, Efrosinia Wark, John BMJ Open Obstetrics and Gynaecology INTRODUCTION: Women at high inherited risk of ovarian cancer are advised to undergo risk-reducing bilateral salpingo-oophorectomy (RRBSO) at age 40–45 years or when their families are complete. Most women are premenopausal at this age, so RRBSO will induce surgical menopause. Despite the clear benefits of RRBSO for cancer risk reduction, much less is known about the impact on non-cancer outcomes that contribute to health and well-being and inform surveillance and management strategies. METHODS AND ANALYSIS: This will be a multicentre, prospective cohort study of 105 premenopausal high-risk women undergoing RRBSO and an age-matched comparison group of 105 premenopausal women not planning oophorectomy or pregnancy in the next 2 years. The aim of this study is to measure the impact of RRBSO on sexual function (primary outcome) at 24 months in high-risk premenopausal women compared with the comparison group. Secondary outcomes include menopausal symptoms and menopause-related quality of life, mood, sleep quality, markers of cardiovascular disease and pre-diabetes, bone density and markers of bone turnover, and the impact of hormone replacement therapy use on these outcomes. Data analysis methods will include logistic and linear regression using general estimating equations accounting for the repeated outcome measurements within each participant. ETHICS AND DISSEMINATION: The study has been approved by institutional ethics committees at each participating centre. Findings will be disseminated through peer-reviewed publications and conference presentations, and national and international networks of centres managing high-risk women, and will inform national and international clinical guidelines. TRIAL REGISTRATION NUMBER: The pre-results protocol for this trial is registered with the Australian New Zealand Clinical Trials Registry (anzctr.org.au; registration no: ACTRN12615000082505). BMJ Publishing Group 2017-11-14 /pmc/articles/PMC5695307/ /pubmed/29138210 http://dx.doi.org/10.1136/bmjopen-2017-018758 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Obstetrics and Gynaecology
Hickey, Martha
Trainer, Alison
Braat, Sabine
Davey, Mary-Ann
Krejany, Efrosinia
Wark, John
What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women
title What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women
title_full What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women
title_fullStr What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women
title_full_unstemmed What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women
title_short What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women
title_sort what happens after menopause? (wham): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women
topic Obstetrics and Gynaecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695307/
https://www.ncbi.nlm.nih.gov/pubmed/29138210
http://dx.doi.org/10.1136/bmjopen-2017-018758
work_keys_str_mv AT hickeymartha whathappensaftermenopausewhamprotocolforaprospectivemulticentreagematchedcohorttrialofriskreducingbilateralsalpingooophorectomyinhighriskpremenopausalwomen
AT traineralison whathappensaftermenopausewhamprotocolforaprospectivemulticentreagematchedcohorttrialofriskreducingbilateralsalpingooophorectomyinhighriskpremenopausalwomen
AT braatsabine whathappensaftermenopausewhamprotocolforaprospectivemulticentreagematchedcohorttrialofriskreducingbilateralsalpingooophorectomyinhighriskpremenopausalwomen
AT daveymaryann whathappensaftermenopausewhamprotocolforaprospectivemulticentreagematchedcohorttrialofriskreducingbilateralsalpingooophorectomyinhighriskpremenopausalwomen
AT krejanyefrosinia whathappensaftermenopausewhamprotocolforaprospectivemulticentreagematchedcohorttrialofriskreducingbilateralsalpingooophorectomyinhighriskpremenopausalwomen
AT warkjohn whathappensaftermenopausewhamprotocolforaprospectivemulticentreagematchedcohorttrialofriskreducingbilateralsalpingooophorectomyinhighriskpremenopausalwomen